Cl Rathi

Jump to

See huge future in nutrition growth, says Advanced Enzyme

CL Rathi, MD of Advanced Enzyme Technologies sees huge future for the company in nutrition growth along with animal nutrition.
Advanced Enzyme targets 25-30% CAGR growth

In an interview to CNBC-TV18, CL Rathi, MD of Advanced Enzyme Technologies spoke about the results and his outlook for the company.
Advanced Enzyme acquires JC Biotech for Rs 50 crore

CL Rathi, Managing Director and Chief Executive of Advanced Enzyme, said the acquisition will be EPS-accretive for FY17 and is likely to have a positive impact for FY18.
Do not need money for capex over next 2-3 yrs: Advanced Enzyme

Do not need any money for capex over next two-three years, says CL Rathi, MD of Advanced Enzyme Technologies.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Cl Rathi

See huge future in nutrition growth, says Advanced Enzyme

Advanced Enzyme targets 25-30% CAGR growth

Advanced Enzyme acquires JC Biotech for Rs 50 crore

Do not need money for capex over next 2-3 yrs: Advanced Enzyme